A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
Open Access
- 22 May 2002
- journal article
- clinical trial
- Published by Springer Nature in BMC Family Practice
- Vol. 3 (1) , 10
- https://doi.org/10.1186/1471-2296-3-10
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Renal Effects of COX-2-Selective InhibitorsAmerican Journal of Nephrology, 2001
- Is the apoE4 allele an independent predictor of coronary events?The American Journal of Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparisonPublished by Elsevier ,1999
- The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritisClinical Therapeutics, 1999
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999
- Guidelines for monitoring drug therapy in rheumatoid arthritisArthritis & Rheumatism, 1996
- Guidelines for the management of rheumatoid arthritisArthritis & Rheumatism, 1996
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Renal Toxicity of the Nonsteroidal Anti-Inflammatory DrugsAnnual Review of Pharmacology and Toxicology, 1993